Model output · Signal date Oct. 14, 2026

Daily SignalsNeutral

2490 companies scored · 2026-10-14 run in progress: 1683 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Create a free account Unlock all ratings

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run

Companies scored 2490 IC ≥ 0 · market cap ≥ $100M

Median forecast +1.01% Total · 30D

Long–short spread +2.21% Strong Buy minus Strong Sell, mean

Median IC 0.28 Spearman · 30D

Rating changes ▲ 92 ▼ 76 vs the previous run

Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

-1.2% 0 +2.3%

Signals · Neutral

67 companies

Sorted by 30D forecast ↓

#	Ticker	Sector	IC	Mkt cap	Rating	30D	90D	Δ
51	RPRXRoyalty Pharma plc	Life Sciences	0.60	$32.5B	Neutral	+0.85%	+3.00%	▲ 1
52	UTHRUNITED THERAPEUTICS Corp	Life Sciences	0.23	$23.6B	Neutral	+0.84%	+0.97%	▲ 1
53	BNTXBioNTech SE	Life Sciences	0.00	$22.5B	Neutral	+0.83%	+2.66%	·
54	INVAInnoviva, Inc.	Life Sciences	0.42	$1.5B	Neutral	+0.81%	+1.21%	·
55	IDXXIDEXX LABORATORIES INC /DE	Life Sciences	0.30	$41.0B	Neutral	+0.80%	+1.59%	·
56	NWBONORTHWEST BIOTHERAPEUTICS INC	Life Sciences	0.03	$277M	Neutral	+0.80%	+2.44%	·
57	PBHPrestige Consumer Healthcare Inc.	Life Sciences	0.36	$2.3B	Neutral	+0.80%	+0.45%	·
58	ABVXAbivax S.A.	Life Sciences	0.16	$6.8B	Neutral	+0.79%	+1.63%	·
59	IVAInventiva S.A.	Life Sciences	0.24	$555M	Neutral	+0.79%	+1.89%	·
60	VTRSViatris Inc	Life Sciences	0.36	$20.1B	Neutral	+0.77%	+2.50%	·
61	CRMDCorMedix Inc.	Life Sciences	0.43	$576M	Neutral	+0.76%	+2.16%	·
62	PAHCPHIBRO ANIMAL HEALTH CORP	Life Sciences	0.47	$1.5B	Neutral	+0.76%	+2.51%	·
63	VCELVericel Corp	Life Sciences	0.27	$2.1B	Neutral	+0.76%	+3.02%	·
64	KRYSKrystal Biotech, Inc.	Life Sciences	0.02	$9.5B	Neutral	+0.75%	+3.14%	·
65	INDVIndivior Pharmaceuticals, Inc.	Life Sciences	0.35	$4.2B	Neutral	+0.73%	+2.97%	▲ 1
66	LKFTLakefront Biotherapeutics NV	Life Sciences	0.33	$1.9B	Neutral	+0.73%	+1.95%	▲ 1
67	RADXRadiopharm Theranostics Ltd	Life Sciences	0.21	$2.6B	Neutral	+0.73%	+0.68%	▲ 1

Breadth

By sector

Median 30D forecast per sector. Click to filter.

Finance or Crypto Assets36 +1.7% Life Sciences289 +1.3% Technology337 +1.1% Manufacturing425 +1.1% Trade & Services324 +1.0% Industrial Applications and Services256 +1.0% Real Estate & Construction207 +0.9% Finance352 +0.9% Energy & Transportation256 +0.9%

Since the previous run

Rating changes

▲ 92▼ 76

Which companies were upgraded or downgraded is part of the paid plans.

Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account

Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.